Trial Profile
A phase III study of L-PPDS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 27 Aug 2015
Price :
$35
*
At a glance
- Drugs Latanoprost (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Mati Therapeutics
- 27 Aug 2015 New trial record